Table 4 Association of plasma Lp(a) levels with cardiovascular disease in a Mendelian randomization analysis (MR-PRESSO)
| Â | N | RAW OR | 95% CI | Estimates P | outlier N | OR | Corrected 95% CI | Estimates P |
|---|---|---|---|---|---|---|---|---|
AA | 11 | 1.005 | 1.000–1.009 | 0.081 | NA | NA | NA | NA |
CHD | 11 | 1.002 | 1.001–1.005 | 0.028 | NA | NA | NA | NA |
ISL | 18 | 1.003 | 1.002–1.004 | 1.40E-06 | NA | NA | NA | NA |
AF | 14 | 1.001 | 1.000–1.002 | 0.081 | NA | NA | NA | NA |
HBP | 16 | 1.000 | 0.998–1.002 | 0.915 | NA | NA | NA | NA |
HF | 12 | 0.999 | 0.997–1.002 | 0.564 | NA | NA | NA | NA |
IS | 16 | 1.000 | 1.000–1.001 | 0.162 | NA | NA | NA | NA |
LIS | 13 | 1.000 | 0.999–1.000 | 0.547 | NA | NA | NA | NA |
ISS | 18 | 0.999 | 0.998–1.000 | 0.445 | NA | NA | NA | NA |
PE | 16 | 0.999 | 0.998–1.000 | 0.228 | NA | NA | NA | NA |